Malaysia's Khazanah backs Chinese lab firm Adicon in US$88m funding round
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
[HONG KONG] Chinese diagnostic lab company Adicon Holdings has closed an US$88 million funding round, led by Malaysian sovereign wealth fund Khazanah Nasional Berhad, Adicon's single largest shareholder Carlyle Group said on Tuesday.
Other investors in this round include Lake Bleu Capital, Cenova Capital, OrbiMed and Mirae Asset, Carlyle said in an announcement.
Based in Southeast Chinese city of Hangzhou, Adicon and its controlled entities operate operates 24 fully-owned diagnostic laboratories in China, offering diagnostic testing outsourcing services to more than 10,000 active customers in 28 provinces.
Adicon is planning an initial public offering after the fundraising, said people with direct knowledge of the matter.
They could not be identified as the information is confidential.
Carlyle, which invested in Adicon in 2018, declined to comment on whether the fundraising was Adicon's pre-IPO round.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
It also declined to disclose Adicon's valuation after the round.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Singaporeans can now buy record amount of yen per Singdollar
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
